{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:27:13Z","timestamp":1793946433559,"version":"4.8.0"},"reference-count":253,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010710","name":"Savitribai Phule Pune University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bbagen.2026.130932","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:27:05Z","timestamp":1773188825000},"page":"130932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Flavonoids: Novel topoisomerase inhibitors in cancer therapy"],"prefix":"10.1016","volume":"1870","author":[{"given":"Priyanka","family":"Mazire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Disha","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bbagen.2026.130932_bb0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2991\/jegh.k.191008.001","article-title":"Current Cancer epidemiology","volume":"9","author":"Mattiuzzi","year":"2019","journal-title":"J. Epidemiol. Glob. Health"},{"issue":"10512","key":"10.1016\/j.bbagen.2026.130932_bb0010","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0140-6736(25)01570-3","article-title":"Global cancer burden: progress, projections, and challenges","volume":"406","author":"Luo","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.bbagen.2026.130932_bb0015","author":"WHO"},{"key":"10.1016\/j.bbagen.2026.130932_bb0020","doi-asserted-by":"crossref","DOI":"10.1177\/10732748251378666","article-title":"Alleviating the global burden of cancer through prevention and early detection","volume":"32","author":"Elbarazi","year":"2025","journal-title":"Cancer Control"},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb0025","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3816\/CLML.2011.n.005","article-title":"Orlowski RZ; DOXIL-MMY-3001 study investigators. Efficacy and safety of pegylated liposomal doxorubicin in combination with bortezomib for multiple myeloma: effects of adverse prognostic factors on outcome","volume":"11","author":"Blad\u00e9","year":"2011","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"7","key":"10.1016\/j.bbagen.2026.130932_bb0030","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1158\/0008-5472.CAN-16-1536","article-title":"Surgery for cancer: a trigger for metastases","volume":"77","author":"Tohme","year":"2017","journal-title":"Cancer Res."},{"issue":"Suppl. 2","key":"10.1016\/j.bbagen.2026.130932_bb0035","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/resp.13870","article-title":"Radiotherapy treatment for lung cancer: current status and future directions","volume":"25","author":"Vinod","year":"2020","journal-title":"Respirology"},{"issue":"6","key":"10.1016\/j.bbagen.2026.130932_bb0040","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2174\/1389200219666180918111528","article-title":"Cancer nanotechnology: a new revolution for cancer diagnosis and therapy","volume":"20","author":"Chaturvedi","year":"2019","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.bbagen.2026.130932_bb0045","doi-asserted-by":"crossref","DOI":"10.1177\/20503121211034366","article-title":"New approaches and procedures for cancer treatment: current perspectives","volume":"9","author":"Debela","year":"2021","journal-title":"SAGE Open Med."},{"key":"10.1016\/j.bbagen.2026.130932_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.100946","article-title":"Recent progress of chemodynamic therapy-induced combination cancer therapy","volume":"35","author":"Wang","year":"2020","journal-title":"Nanotoday"},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy: a novel approach to reversing drug resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.bbagen.2026.130932_bb0060","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3892\/ijo.2018.4661","article-title":"From chemotherapy to biological therapy: a review of novel concepts to reduce the side effects of systemic cancer treatment (review)","volume":"54","author":"Schirrmacher","year":"2019","journal-title":"Int. J. Oncol."},{"issue":"12","key":"10.1016\/j.bbagen.2026.130932_bb0065","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.3390\/molecules26123583","article-title":"Flavonoids: a myth or a reality for cancer therapy?","volume":"26","author":"Forni","year":"2021","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.bbagen.2026.130932_bb0070","doi-asserted-by":"crossref","first-page":"384S","DOI":"10.3945\/an.112.003517","article-title":"Health-promoting components of fruits and vegetables in the diet","volume":"4","author":"Liu","year":"2013","journal-title":"Adv. Nutr."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb0075","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/cancers11010028","article-title":"Flavonoids in cancer and apoptosis","volume":"11","author":"Abotaleb","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.bbagen.2026.130932_bb0080","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1042\/BCJ20160583","article-title":"Topoisomerases as anticancer targets","volume":"475","author":"Delgado","year":"2018","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbagen.2026.130932_bb0085","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/0929867003375489","article-title":"Topoisomerase I poisons and suppressors as anticancer drugs","volume":"7","author":"Bailly","year":"2000","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"10.1016\/j.bbagen.2026.130932_bb0090","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.chembiol.2010.04.012","article-title":"DNA topoisomerases and their poisoning by anticancer and antibacterial drugs","volume":"17","author":"Pommier","year":"2010","journal-title":"Chem. Biol."},{"issue":"10","key":"10.1016\/j.bbagen.2026.130932_bb0095","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrc1977","article-title":"Topoisomerase I inhibitors: camptothecins and beyond","volume":"6","author":"Pommier","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"22","key":"10.1016\/j.bbagen.2026.130932_bb0100","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1158\/1078-0432.CCR-19-1089","article-title":"Targeting topoisomerase I in the era of precision medicine","volume":"25","author":"Thomas","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbagen.2026.130932_bb0105","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ejmech.2018.01.010","article-title":"Synthesis of carbazole derivatives containing chalcone analogs as non-intercalative topoisomerase II catalytic inhibitors and apoptosis inducers","volume":"145","author":"Li","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbagen.2026.130932_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107457","article-title":"Flavonoids and their derivatives as DNA topoisomerase inhibitors with anti-cancer activity in various cell models: exploring a novel mode of action","volume":"209","author":"Sitarek","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb0115","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/1389202917666160808125213","article-title":"Natural compounds as anticancer agents targeting DNA topoisomerases","volume":"18","author":"Jain","year":"2017","journal-title":"Curr. Genomics"},{"key":"10.1016\/j.bbagen.2026.130932_bb0120","unstructured":"Ferlay J, Laversanne M, Ervik M, Lam F, Colombet M, Mery L, Pi\u00f1eros M, Znaor A, Soerjomataram I, Bray F. Global Cancer Observatory: Cancer Tomorrow (version 1.1), 2024. Lyon, France: International Agency for Research on Cancer. Available from: https:\/\/gco.iarc.who.int\/tomorrow, accessed (29-01-2026)."},{"issue":"22","key":"10.1016\/j.bbagen.2026.130932_bb0125","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.3390\/healthcare11222920","article-title":"Epidemiological analysis of global and regional lung cancer mortality: based on 30-year data analysis of global burden disease database","volume":"11","author":"Ji","year":"2023","journal-title":"Healthcare (Basel)"},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb0130","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb0135","doi-asserted-by":"crossref","first-page":"19","DOI":"10.15420\/ecr.2015.10.01.19","article-title":"Chemotherapy-related cardiomyopathy","volume":"10","author":"Piper","year":"2015","journal-title":"Eur. Cardiol."},{"issue":"4","key":"10.1016\/j.bbagen.2026.130932_bb0140","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","article-title":"Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics","volume":"10","author":"Anand","year":"2022","journal-title":"Genes Dis."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb0145","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12943-019-1058-3","article-title":"Surgical stress and cancer progression: the twisted tango","volume":"18","author":"Chen","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbagen.2026.130932_bb0150","series-title":"StatPearls Internet","article-title":"Adverse effects of radiation therapy","author":"Majeed","year":"2022"},{"issue":"4","key":"10.1016\/j.bbagen.2026.130932_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e42682","article-title":"Phytochemical insights into flavonoids in cancer: mechanisms, therapeutic potential, and the case of quercetin","volume":"11","author":"Silva-Pinto","year":"2025","journal-title":"Heliyon"},{"issue":"19","key":"10.1016\/j.bbagen.2026.130932_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/app151910840","article-title":"A comprehensive review of biological properties of flavonoids and their role in the prevention of metabolic, cancer and neurodegenerative diseases","volume":"15","author":"Stachelska","year":"2025","journal-title":"Appl. Sci."},{"key":"10.1016\/j.bbagen.2026.130932_bb0165","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fpls.2012.00222","article-title":"Flavonoids: biosynthesis, biological functions, and biotechnological applications","volume":"3","author":"Falcone Ferreyra","year":"2012","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.bbagen.2026.130932_bb0170","doi-asserted-by":"crossref","DOI":"10.1017\/jns.2016.41","article-title":"Flavonoids: an overview","volume":"5","author":"Panche","year":"2016","journal-title":"J. Nutr. Sci."},{"key":"10.1016\/j.bbagen.2026.130932_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2022.132531","article-title":"Plant flavonoids: classification, distribution, biosynthesis, and antioxidant activity","volume":"383","author":"Shen","year":"2022","journal-title":"Food Chem."},{"issue":"12","key":"10.1016\/j.bbagen.2026.130932_bb0180","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1016\/j.biocel.2013.10.004","article-title":"Flavonoids as prospective compounds for anti-cancer therapy","volume":"45","author":"Ravishankar","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbagen.2026.130932_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112442","article-title":"Therapeutic potential of flavonoids in cancer: ROS-mediated mechanisms","volume":"146","author":"Slika","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb0190","article-title":"Ginkgo biloba leaf extract induces DNA damage by inhibiting topoisomerase II activity in human hepatic cells","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.bbagen.2026.130932_bb0195","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.3390\/ijms25105569","article-title":"Apigenin: molecular mechanisms and therapeutic potential against cancer spreading","volume":"25","author":"Naponelli","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb0200","doi-asserted-by":"crossref","first-page":"8858","DOI":"10.1038\/s41598-022-11441-z","article-title":"The effect of apigenin and chemotherapy combination treatments on apoptosis-related genes and proteins in acute leukaemia cell lines","volume":"12","author":"Mahbub","year":"2022","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.bbagen.2026.130932_bb0205","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.21873\/anticanres.16742","article-title":"Genistein induces antiproliferative activity and apoptosis in human osteosarcoma Saos-2 cells","volume":"43","author":"Hagiwara","year":"2023","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb0210","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/ijms19010027","article-title":"Antiangiogenic effect of flavonoids and chalcones: an update","volume":"19","author":"Mirossay","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb0215","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-63136-2","article-title":"Anti-metastasis activity of 5,4\u2032-dihydroxy 6,8-dimethoxy 7-O-rhamnosyl flavone from Indigofera aspalathoides Vahl on breast cancer cells","volume":"14","author":"Al-Saeedi","year":"2024","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.bbagen.2026.130932_bb0220","doi-asserted-by":"crossref","first-page":"8824","DOI":"10.3390\/ijms24108824","article-title":"Multi-faceted role of Luteolin in Cancer metastasis: EMT, angiogenesis, ECM degradation and apoptosis","volume":"24","author":"Rocchetti","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.bbagen.2026.130932_bb0225","doi-asserted-by":"crossref","first-page":"9236","DOI":"10.3390\/ijms24119236","article-title":"Effects of flavonoids on cancer, cardiovascular and neurodegenerative diseases: role of NF-\u03baB signaling pathway","volume":"24","author":"Barreca","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bbagen.2026.130932_bb0230","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0022-2836(71)90334-2","article-title":"Interaction between DNA and an Escherichia coli protein omega","volume":"55","author":"Wang","year":"1971","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb0235","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1073\/pnas.69.1.143","article-title":"An activity from mammalian cells that untwists superhelical DNA--a possible swivel for DNA replication (polyoma-ethidium bromide-mouse-embryo cells-dye binding assay)","volume":"69","author":"Champoux","year":"1972","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.bbagen.2026.130932_bb0240","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.3390\/molecules26113375","article-title":"DNA-topology simplification by topoisomerases","volume":"26","author":"Hanke","year":"2021","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.bbagen.2026.130932_bb0245","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3109\/07357909409021413","article-title":"Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors","volume":"12","author":"Pommier","year":"1994","journal-title":"Cancer Investig."},{"issue":"Pt 2","key":"10.1016\/j.bbagen.2026.130932_bb0250","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1042\/bj20020098","article-title":"Luteolin, an emerging anti-cancer flavonoid, poisons eukaryotic DNA topoisomerase I","volume":"366","author":"Chowdhury","year":"2002","journal-title":"Biochem. J."},{"issue":"7","key":"10.1016\/j.bbagen.2026.130932_bb0255","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1021\/cr900097c","article-title":"DNA topoisomerase I inhibitors: chemistry, biology, and interfacial inhibition","volume":"109","author":"Pommier","year":"2009","journal-title":"Chem. Rev."},{"issue":"4","key":"10.1016\/j.bbagen.2026.130932_bb0260","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/1568011033482378","article-title":"Apoptosis induced by topoisomerase inhibitors","volume":"3","author":"Sordet","year":"2003","journal-title":"Curr. Med. Chem. Anticancer Agents"},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb0265","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1080\/14756366.2020.1821676","article-title":"DNA topoisomerases as molecular targets for anticancer drugs","volume":"35","author":"Buzun","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bbagen.2026.130932_bb0270","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.biochem.70.1.369","article-title":"DNA topoisomerases: structure, function, and mechanism","volume":"70","author":"Champoux","year":"2001","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbagen.2026.130932_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.mrgentox.2020.503144","article-title":"Bioflavonoids cause DNA double-strand breaks and chromosomal translocations through topoisomerase II-dependent and -independent mechanisms","volume":"849","author":"Goodenow","year":"2020","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen."},{"issue":"27","key":"10.1016\/j.bbagen.2026.130932_bb0280","doi-asserted-by":"crossref","first-page":"14873","DOI":"10.1016\/S0021-9258(17)38654-4","article-title":"Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I","volume":"260","author":"Hsiang","year":"1985","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb0285","first-page":"18","article-title":"Topoisomerase IB: a relaxing enzyme for stressed DNA","volume":"3","author":"Soren","year":"2020","journal-title":"Cancer Drug Resist."},{"issue":"3","key":"10.1016\/j.bbagen.2026.130932_bb0290","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.3390\/ijms24032532","article-title":"A Mini review of novel topoisomerase II inhibitors as future anticancer agents","volume":"24","author":"Okoro","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.bbagen.2026.130932_bb0295","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrm.2016.111","article-title":"Roles of eukaryotic topoisomerases in transcription, replication and genomic stability","volume":"17","author":"Pommier","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.bbagen.2026.130932_bb0300","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/nar\/gkv1152","article-title":"The role of topoisomerase I in suppressing genome instability associated with a highly transcribed guanine-rich sequence is not restricted to preventing RNA: DNA hybrid accumulation","volume":"44","author":"Yadav","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbagen.2026.130932_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.mrgentox.2022.503450","article-title":"Emerging roles of DNA topoisomerases in the regulation of R-loops","volume":"876-877","author":"Patel","year":"2022","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen."},{"issue":"12","key":"10.1016\/j.bbagen.2026.130932_bb0310","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1038\/bjc.1996.286","article-title":"Differential expression of the topoisomerase II alpha and beta genes in human breast cancers","volume":"73","author":"Sandri","year":"1996","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbagen.2026.130932_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104551","article-title":"Topoisomerase inhibitors: pharmacology and emerging nanoscale delivery systems","volume":"151","author":"Dehshahri","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.bbagen.2026.130932_bb0320","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2174\/1568011043352777","article-title":"Camptothecins and topoisomerase I: a foot in the door. Targeting the genome beyond topoisomerase I with camptothecins and novel anticancer drugs: importance of DNA replication, repair and cell cycle checkpoints","volume":"4","author":"Pommier","year":"2004","journal-title":"Curr. Med. Chem. Anticancer Agents"},{"key":"10.1016\/j.bbagen.2026.130932_bb0325","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.20201.1","article-title":"Topoisomerases and cancer chemotherapy: recent advances and unanswered questions","volume":"8","author":"Bjornsti","year":"2019","journal-title":"F1000Res"},{"issue":"3","key":"10.1016\/j.bbagen.2026.130932_bb0330","doi-asserted-by":"crossref","first-page":"293","DOI":"10.22270\/jddt.v10i3.4075","article-title":"Phytochemicals in cancer treatment: a review","volume":"10","author":"Venkatajalapathi","year":"2020","journal-title":"J. Drug Deliv. Therap."},{"key":"10.1016\/j.bbagen.2026.130932_bb0335","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejmech.2017.07.034","article-title":"Recent discoveries of anticancer flavonoids","volume":"142","author":"Raffa","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bbagen.2026.130932_bb0340","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/17460441.2019.1573812","article-title":"Recent developments in biological aspects of chalcones: the odyssey continues","volume":"14","author":"Rani","year":"2019","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bbagen.2026.130932_bb0345","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7651047","article-title":"Chalcone scaffold in anticancer armamentarium: a molecular insight","volume":"2016","author":"Das","year":"2016","journal-title":"J Toxicol."},{"issue":"7","key":"10.1016\/j.bbagen.2026.130932_bb0350","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3390\/cells12071066","article-title":"Chalcone derivative CX258 suppresses colorectal cancer via inhibiting the TOP2A\/Wnt\/\u03b2-catenin signaling","volume":"12","author":"Chen","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.bbagen.2026.130932_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152921","article-title":"Ellagic acid synergistically potentiates inhibitory activities of chemotherapeutic agents to human hepatocellular carcinoma","volume":"59","author":"Zhong","year":"2019","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.bbagen.2026.130932_bb0360","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s40495-019-00181-w","article-title":"Ellagic acid, Kaempferol, and quercetin from Acacia nilotica: promising combined drug with multiple mechanisms of action","volume":"5","author":"Al-Nour","year":"2019","journal-title":"Curr. Pharmacol. Rep."},{"issue":"4","key":"10.1016\/j.bbagen.2026.130932_bb0365","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/ptr.6317","article-title":"Antitumour effects of selected plant polyphenols, gallic acid and ellagic acid, on sensitive and multidrug-resistant leukaemia HL60 cells","volume":"33","author":"Maruszewska","year":"2019","journal-title":"Phytother. Res."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb0370","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3390\/cancers13010115","article-title":"Perspectives on the role of isoliquiritigenin in cancer","volume":"13","author":"Wang","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbagen.2026.130932_bb0375","first-page":"2935","article-title":"Advances of wogonin, an extract from Scutellaria baicalensis, for the treatment of multiple tumors","volume":"9","author":"Wu","year":"2016","journal-title":"Onco. Targets Ther."},{"issue":"5","key":"10.1016\/j.bbagen.2026.130932_bb0380","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1002\/ptr.7386","article-title":"Wogonin and its analogs for the prevention and treatment of cancer: a systematic review","volume":"36","author":"Banik","year":"2022","journal-title":"Phytother. Res."},{"issue":"2","key":"10.1016\/j.bbagen.2026.130932_bb0385","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.canlet.2008.12.005","article-title":"Isoliquiritigenin induces G2 and M phase arrest by inducing DNA damage and by inhibiting the metaphase\/anaphase transition","volume":"277","author":"Park","year":"2009","journal-title":"Cancer Lett."},{"issue":"10","key":"10.1016\/j.bbagen.2026.130932_bb0390","first-page":"12577","article-title":"Inhibitory effect of DNA topoisomerase inhibitor isoliquiritigenin on the growth of glioma cells","volume":"8","author":"Zhao","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"2","key":"10.1016\/j.bbagen.2026.130932_bb0395","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.bbrc.2015.07.003","article-title":"Novel insights into the apoptosis mechanism of DNA topoisomerase I inhibitor isoliquiritigenin on HCC tumor cell","volume":"464","author":"Li","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2026.130932_bb0400","series-title":"Studies in Natural Products Chemistry","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/B978-0-444-63929-5.00002-4","article-title":"Advances in the chemistry of natural and semisynthetic topoisomerase I\/II inhibitors","author":"D\u2019yakonov","year":"2017"},{"issue":"31","key":"10.1016\/j.bbagen.2026.130932_bb0405","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.2174\/092986712803833272","article-title":"Flavonoids acting on DNA topoisomerases: recent advances and future perspectives in cancer therapy","volume":"19","author":"Russo","year":"2012","journal-title":"Curr. Med. Chem."},{"issue":"32","key":"10.1016\/j.bbagen.2026.130932_bb0410","doi-asserted-by":"crossref","first-page":"52281","DOI":"10.18632\/oncotarget.10739","article-title":"Millepachine, a potential topoisomerase II inhibitor induces apoptosis via activation of NF-\u03baB pathway in ovarian cancer","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.bbagen.2026.130932_bb0415","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1002\/ptr.6180","article-title":"Millepachine showed novel antitumor effects in cisplatin-resistant human ovarian cancer through inhibiting drug efflux function of ATP-binding cassette transporters","volume":"32","author":"Wu","year":"2018","journal-title":"Phytother. Res."},{"issue":"14","key":"10.1016\/j.bbagen.2026.130932_bb0420","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.3390\/molecules25143180","article-title":"Design, synthesis and anti-tumor activity of novel benzimidazole-chalcone hybrids as non-intercalative topoisomerase II catalytic inhibitors","volume":"25","author":"Zhou","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb0425","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/14756366.2018.1507029","article-title":"Computational screening of chalcones acting against topoisomerase II\u03b1 and their cytotoxicity towards cancer cell lines","volume":"34","author":"Sangpheak","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"10","key":"10.1016\/j.bbagen.2026.130932_bb0430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162821","article-title":"Dual inhibition of topoisomerase II and tyrosine kinases by the novel Bis-fluoroquinolone chalcone-like derivative HMNE3 in human pancreatic cancer cells","volume":"11","author":"Ma","year":"2016","journal-title":"PLoS ONE"},{"issue":"13","key":"10.1016\/j.bbagen.2026.130932_bb0435","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.3390\/ijms20133177","article-title":"The anti cancer effect of quercetin: molecular implications in cancer metabolism","volume":"20","author":"Reyes-Farias","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bbagen.2026.130932_bb0440","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3390\/pharmaceutics15020712","article-title":"Apoptotic mechanisms of quercetin in liver cancer: recent trends and advancements","volume":"15","author":"Sethi","year":"2023","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.bbagen.2026.130932_bb0445","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s12029-017-9997-7","article-title":"Rahimi R.J A comprehensive review on pharmacotherapeutics of three phytochemicals, curcumin, quercetin, and allicin, in the treatment of gastric cancer","volume":"48","author":"Haghi","year":"2017","journal-title":"Gastrointest Cancer."},{"key":"10.1016\/j.bbagen.2026.130932_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117463","article-title":"A review on anti-cancer properties of quercetin in breast cancer","volume":"248","author":"Ezzati","year":"2020","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb0455","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10787-019-00660-y","article-title":"Therapeutic potential of quercetin on human breast cancer in different dimensions","volume":"28","author":"Kasiri","year":"2020","journal-title":"Inflammopharma"},{"key":"10.1016\/j.bbagen.2026.130932_bb0460","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13578-020-00397-0","article-title":"Quercetin and cancer: new insights into its therapeutic effects on ovarian cancer cells","volume":"10","author":"Vafadar","year":"2020","journal-title":"Cell Biosci."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb0465","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s11658-022-00355-3","article-title":"Quercetin as a JAK-STAT inhibitor: a potential role in solid tumors and neurodegenerative diseases","volume":"27","author":"Zalpoor","year":"2022","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"2","key":"10.1016\/j.bbagen.2026.130932_bb0470","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1021\/np50116a009","article-title":"Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships","volume":"58","author":"Constantinou","year":"1995","journal-title":"J. Nat. Prod."},{"issue":"7","key":"10.1016\/j.bbagen.2026.130932_bb0475","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.freeradbiomed.2011.06.021","article-title":"Potency of inhibition of human DNA topoisomerase I by flavones assessed through physicochemical parameters","volume":"51","author":"Bensasson","year":"2011","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.bbagen.2026.130932_bb0480","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/ijc.30497","article-title":"Quercetin alters the DNA damage response in human hematopoietic stem and progenitor cells via TopoII- and PI3K-dependent mechanisms synergizing in leukemogenic rearrangements","volume":"140","author":"Biechonski","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.bbagen.2026.130932_bb0485","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/10799893.2020.1805628","article-title":"Analysis of plant-derived phytochemicals as anti-cancer agents targeting cyclin dependent kinase-2, human topoisomerase IIa and vascular endothelial growth factor receptor-2","volume":"41","author":"Sarkar","year":"2021","journal-title":"J. Recept. Signal Transduct. Res."},{"issue":"7","key":"10.1016\/j.bbagen.2026.130932_bb0490","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.7150\/ijbs.41686","article-title":"Quercetin reverses docetaxel resistance in prostate cancer via androgen receptor and PI3K\/Akt signaling pathways","volume":"16","author":"Lu","year":"2020","journal-title":"Int. J. Biol. Sci."},{"issue":"17","key":"10.1016\/j.bbagen.2026.130932_bb0495","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.4155\/fmc-2017-0118","article-title":"New insights for the use of quercetin analogs in cancer treatment","volume":"9","author":"Iacopetta","year":"2017","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bbagen.2026.130932_bb0500","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ejps.2017.08.013","article-title":"Quercetin exerts synergetic anti-cancer activity with 10-hydroxy camptothecin","volume":"109","author":"Tang","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bbagen.2026.130932_bb0505","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jnutbio.2017.09.011","article-title":"Effects of quercetin combined with anticancer drugs on metastasis-associated factors of gastric cancer cells: in vitro and in vivo studies","volume":"51","author":"Lei","year":"2018","journal-title":"J. Nutr. Biochem."},{"issue":"11","key":"10.1016\/j.bbagen.2026.130932_bb0510","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1016\/j.xphs.2023.08.014","article-title":"Combinatorial effect of doxorubicin entrapped in alginate-chitosan hybrid polymer and cerium oxide nanocomposites on skin cancer management in mice","volume":"112","author":"Shurfa","year":"2023","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bbagen.2026.130932_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109506","article-title":"Anti-tumor effects and associated molecular mechanisms of myricetin","volume":"120","author":"Jiang","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb0520","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.mrgentox.2009.12.010","article-title":"The dietary flavonoids myricetin and fisetin act as dual inhibitors of DNA topoisomerases I and II in cells","volume":"696","author":"L\u00f3pez-L\u00e1zaro","year":"2010","journal-title":"Mutat. Res."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb0525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00210-019-01692-5","article-title":"Sensitization of MDA-MBA231 breast cancer cell to docetaxel by myricetin loaded into biocompatible lipid nanoparticles via sub-G1 cell cycle arrest mechanism","volume":"393","author":"Maroufi","year":"2020","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbagen.2026.130932_bb0530","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/jmf.2020.0033","article-title":"Myricitrin from Combretum lanceolatum exhibits inhibitory effect on DNA-topoisomerase type II\u03b1 and protective effect against in vivo doxorubicin-induced mutagenicity","volume":"24","author":"Perdomo","year":"2021","journal-title":"J. Med. Food"},{"issue":"28","key":"10.1016\/j.bbagen.2026.130932_bb0535","doi-asserted-by":"crossref","first-page":"9580","DOI":"10.1080\/10408398.2022.2067121","article-title":"Kaempferol: a flavonoid with wider biological activities and its applications","volume":"63","author":"Bangar","year":"2023","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"6","key":"10.1016\/j.bbagen.2026.130932_bb0540","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3727\/096504018X15228018559434","article-title":"Kaempferol suppresses proliferation and induces cell cycle arrest, apoptosis, and DNA damage in breast cancer cells","volume":"27","author":"Zhu","year":"2019","journal-title":"Oncol. Res."},{"issue":"7","key":"10.1016\/j.bbagen.2026.130932_bb0545","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.3390\/ijms22073520","article-title":"Kaempferol and its glycoside derivatives as modulators of etoposide activity in HL-60 cells","volume":"22","author":"Kluska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bbagen.2026.130932_bb0550","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155264","article-title":"Kaempferol inhibits pancreatic cancer cell growth and migration through the blockade of EGFR-related pathway in vitro","volume":"11","author":"Lee","year":"2016","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.bbagen.2026.130932_bb0555","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3390\/ph16020196","article-title":"Fisetin in cancer: attributes, developmental aspects, and nanotherapeutics","volume":"16","author":"Kumar","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"6","key":"10.1016\/j.bbagen.2026.130932_bb0560","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/mnfr.201600025","article-title":"Dietary flavonoid fisetin for cancer prevention and treatment","volume":"60","author":"Lall","year":"2016","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.bbagen.2026.130932_bb0565","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.biopha.2017.10.164","article-title":"A review on the chemotherapeutic potential of fisetin: in vitro evidences","volume":"97","author":"Sundarraj","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.bbagen.2026.130932_bb0570","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241805","article-title":"Toxicodendron vernicifluum Stokes extract inhibits solid tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells in BALB\/c mice","volume":"15","author":"Lee","year":"2020","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb0575","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12906-018-2127-7","article-title":"Fisetin and polymeric micelles encapsulating fisetin exhibit potent cytotoxic effects towards ovarian cancer cells","volume":"18","author":"Xiao","year":"2018","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.bbagen.2026.130932_bb0580","article-title":"Designing fisetin nanocrystals for enhanced in cellulo anti-angiogenic and anticancer efficacy","volume":"4","author":"Ma","year":"2022","journal-title":"Int. J. Pharm. X"},{"issue":"7","key":"10.1016\/j.bbagen.2026.130932_bb0585","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3390\/pharmaceutics13070970","article-title":"Co-encapsulation of Fisetin and cisplatin into liposomes for glioma therapy: from formulation to cell evaluation","volume":"1f","author":"Renault-Mahieux","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bbagen.2026.130932_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154095","article-title":"Casticin and chrysosplenol D from Artemisia annua L. induce apoptosis by inhibiting topoisomerase II\u03b1 in human non-small-cell lung cancer cells","volume":"100","author":"Fu","year":"2022","journal-title":"Phytomedicine"},{"issue":"5","key":"10.1016\/j.bbagen.2026.130932_bb0595","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3390\/genes13050815","article-title":"Casticin impacts key signaling pathways in colorectal cancer cells leading to cell death with therapeutic implications","volume":"13","author":"Kowalski","year":"2022","journal-title":"Genes (Basel)"},{"issue":"4","key":"10.1016\/j.bbagen.2026.130932_bb0600","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.3892\/or.2016.5027","article-title":"Casticin induces DNA damage and inhibits DNA repair-associated protein expression in B16F10 mouse melanoma cancer cells","volume":"36","author":"Shih","year":"2016","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.bbagen.2026.130932_bb0605","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3390\/molecules25020341","article-title":"Casticin induces DNA damage and affects DNA repair associated protein expression in human lung Cancer A549 cells (running title: Casticin induces DNA damage in lung cancer cells)","volume":"25","author":"Cheng","year":"2020","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.bbagen.2026.130932_bb0610","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/01635581.2019.1637006","article-title":"The role of polyphenol (flavonoids) compounds in the treatment of cancer cells","volume":"72","author":"Hazafa","year":"2020","journal-title":"Nutr. Cancer"},{"issue":"5","key":"10.1016\/j.bbagen.2026.130932_bb0615","first-page":"3873","article-title":"Epigallocatechin gallate induces chemopreventive effects on rats with diethylnitrosamine-induced liver cancer via inhibition of cell division cycle 25A","volume":"22","author":"Tang","year":"2020","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb0620","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1006\/bbrc.2001.5736","article-title":"Green tea constituent (\u2212-)-epigallocatechin-3-gallate inhibits topoisomerase I activity in human colon carcinoma cells","volume":"288","author":"Berger","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.bbagen.2026.130932_bb0625","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1021\/acsbiomaterials.8b00242","article-title":"Active tumor-targeted co-delivery of epigallocatechin gallate and doxorubicin in nanoparticles for combination gastric cancer therapy","volume":"4","author":"Mi","year":"2018","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"8","key":"10.1016\/j.bbagen.2026.130932_bb0630","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.3390\/molecules24081580","article-title":"Enoxacin and epigallocatechin gallate (EGCG) act synergistically to inhibit the growth of cervical cancer cells in culture","volume":"24","author":"McDonnell","year":"2019","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.bbagen.2026.130932_bb0635","doi-asserted-by":"crossref","first-page":"407","DOI":"10.38001\/ijlsb.1089164","article-title":"Antitumor activity of etoposide, puerarin, galangin and their combinations in neuroblastoma cells","volume":"5","author":"Oltulu","year":"2022","journal-title":"Int. J. Life Sci. Biotech."},{"issue":"2","key":"10.1016\/j.bbagen.2026.130932_bb0640","first-page":"89","article-title":"Bioassay guided isolation of topoisomerase \u0399 poison from Paphiopedilum callosum (Rchb.F.) stein","volume":"14","author":"Nwe","year":"2020","journal-title":"Rec. Nat. Prod."},{"issue":"4","key":"10.1016\/j.bbagen.2026.130932_bb0645","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1074\/jbc.271.4.2262","article-title":"Selected novel flavones inhibit the DNA binding or the DNA religation step of eukaryotic topoisomerase I","volume":"271","author":"Boege","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bbagen.2026.130932_bb0650","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00404-018-4912-4","article-title":"Morin decreases galectin-3 expression and sensitizes ovarian cancer cells to cisplatin","volume":"298","author":"Bieg","year":"2018","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.bbagen.2026.130932_bb0655","doi-asserted-by":"crossref","DOI":"10.1177\/2515690X211068826","article-title":"Role of Silymarin in cancer treatment: facts, hypotheses, and questions","volume":"27","author":"Koltai","year":"2022","journal-title":"J. Evid. Based Integr. Med."},{"issue":"10","key":"10.1016\/j.bbagen.2026.130932_bb0660","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1158\/0008-5472.CAN-04-4662","article-title":"Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells","volume":"65","author":"Davis-Searles","year":"2005","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb0665","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000175466","article-title":"2,3-dehydrosilybin is a better DNA topoisomerase I inhibitor than its parental silybin","volume":"55","author":"Thongphasuk","year":"2009","journal-title":"Chemotherapy"},{"issue":"5","key":"10.1016\/j.bbagen.2026.130932_bb0670","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1089\/jmf.2010.1021","article-title":"Phenolic-containing organic extracts of mulberry (Morus alba L.) leaves inhibit HepG2 hepatoma cells through G2\/M phase arrest, induction of apoptosis, and inhibition of topoisomerase II\u03b1 activity","volume":"13","author":"Naowaratwattana","year":"2010","journal-title":"J. Med. Food"},{"issue":"7","key":"10.1016\/j.bbagen.2026.130932_bb0675","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1021\/jf048524w","article-title":"Effects of grape cell culture extracts on human topoisomerase II catalytic activity and characterization of active fractions","volume":"53","author":"Jo","year":"2005","journal-title":"J. Agric. Food Chem."},{"issue":"7","key":"10.1016\/j.bbagen.2026.130932_bb0680","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1002\/ptr.7044","article-title":"Anticancer activity of the plant flavonoid luteolin against preclinical models of various cancers and insights on different signalling mechanisms modulated","volume":"35","author":"Ganai","year":"2021","journal-title":"Phytother. Res."},{"issue":"1\u20132","key":"10.1016\/j.bbagen.2026.130932_bb0685","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1515\/znc-2008-1-213","article-title":"Flavonoids in Helichrysum pamphylicum inhibit mammalian type I DNA topoisomerase","volume":"63","author":"Topcu","year":"2008","journal-title":"Z Naturforsch C J Biosci."},{"key":"10.1016\/j.bbagen.2026.130932_bb0690","first-page":"89","article-title":"Mechanism of metastasis suppression by luteolin in breast cancer","volume":"10","author":"Cook","year":"2018","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"10.1016\/j.bbagen.2026.130932_bb0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152883","article-title":"Apoptosis induced by luteolin in breast cancer: mechanistic and therapeutic perspectives","volume":"59","author":"Ahmed","year":"2019","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.bbagen.2026.130932_bb0700","doi-asserted-by":"crossref","first-page":"10998","DOI":"10.1080\/21655979.2022.2066926","article-title":"Luteolin impacts deoxyribonucleic acid repair by modulating the mitogen-activated protein kinase pathway in colorectal cancer","volume":"13","author":"Song","year":"2022","journal-title":"Bioengineer"},{"issue":"6","key":"10.1016\/j.bbagen.2026.130932_bb0705","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s40495-017-0113-2","article-title":"Plant flavone apigenin: an emerging anticancer agent","volume":"3","author":"Shankar","year":"2017","journal-title":"Curr. Pharmacol. Rep."},{"key":"10.1016\/j.bbagen.2026.130932_bb0710","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2017.10.041","article-title":"Apigenin: a dietary flavonoid with diverse anticancer properties","volume":"413","author":"Maduni\u0107","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbagen.2026.130932_bb0715","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.3389\/fpls.2017.01521","article-title":"Screening for natural inhibitors of topoisomerases I from Rhamnus davurica by affinity ultrafiltration and high-performance liquid chromatography-mass spectrometry","volume":"8","author":"Chen","year":"2017","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.bbagen.2026.130932_bb0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcab.2019.101243","article-title":"Acalypha wilkesiana flowers: phenolic profiling, cytotoxic activity of their biosynthesized silver nanoparticles and molecular docking study for its constituents as topoisomerase-I inhibitors","volume":"20","author":"El Raey","year":"2019","journal-title":"Biocatal. Agric. Biotechnol."},{"key":"10.1016\/j.bbagen.2026.130932_bb0725","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1086894","article-title":"Apigenin directly interacts with and inhibits topoisomerase 1 to upregulate CD26\/DPP4 on colorectal carcinoma cells","volume":"13","author":"Fux","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"31","key":"10.1016\/j.bbagen.2026.130932_bb0730","doi-asserted-by":"crossref","first-page":"47539","DOI":"10.1007\/s11356-022-19166-2","article-title":"Potential of green-synthesized selenium nanoparticles using apigenin in human breast cancer MCF-7 cells","volume":"29","author":"Al-Otaibi","year":"2022","journal-title":"Environ. Sci. Pollut. Res. Int."},{"issue":"17","key":"10.1016\/j.bbagen.2026.130932_bb0735","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.3390\/polym14173577","article-title":"Apigenin loaded lipoid-PLGA-TPGS nanoparticles for colon cancer therapy: characterization, sustained release, cytotoxicity, and apoptosis pathways","volume":"14","author":"Alfaleh","year":"2022","journal-title":"Polymers (Basel)"},{"issue":"2","key":"10.1016\/j.bbagen.2026.130932_bb0740","doi-asserted-by":"crossref","first-page":"125","DOI":"10.32471\/exp-oncology.2312-8852.vol-43-no-2.16096","article-title":"Co-administration of apigenin with doxorubicin enhances anti-migration and antiproliferative effects via PI3K\/PTEN\/AKT pathway in prostate cancer cells","volume":"43","author":"Ayyildiz","year":"2021","journal-title":"Exp. Oncol."},{"key":"10.1016\/j.bbagen.2026.130932_bb0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102144","article-title":"Apigenin enhances apoptosis induction by 5-fluorouracil through regulation of thymidylate synthase in colorectal cancer cells","volume":"47","author":"Yang","year":"2021","journal-title":"Redox Biol."},{"issue":"9","key":"10.1016\/j.bbagen.2026.130932_bb0750","doi-asserted-by":"crossref","first-page":"8777","DOI":"10.1007\/s11033-022-07727-0","article-title":"Apigenin alleviates resistance to doxorubicin in breast cancer cells by acting on the JAK\/STAT signaling pathway","volume":"49","author":"Maashi","year":"2022","journal-title":"Mol. Biol. Rep."},{"issue":"5","key":"10.1016\/j.bbagen.2026.130932_bb0755","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3892\/etm.2021.9936","article-title":"Critical roles of Rad54 in tolerance to apigenin-induced Top1-mediated DNA damage","volume":"21","author":"Zhao","year":"2021","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb0760","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12906-023-04046-0","article-title":"Cytotoxic flavone-C-glycosides from the leaves of Dypsis pembana (H.E.Moore) Beentje & J.Dransf., Arecaceae: in vitro and molecular docking studies","volume":"23","author":"Abdelrahim","year":"2023","journal-title":"BMC Complement Med Ther."},{"key":"10.1016\/j.bbagen.2026.130932_bb0765","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118183","article-title":"Baicalein: a metabolite with promising antineoplastic activity","volume":"259","author":"Tuli","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.bbagen.2026.130932_bb0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105387","article-title":"Baicalin mediated regulation of key signaling pathways in cancer","volume":"164","author":"Singh","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"Pt 3","key":"10.1016\/j.bbagen.2026.130932_bb0775","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1042\/bj2820883","article-title":"Site-specific DNA cleavage by mammalian DNA topoisomerase II induced by novel flavone and catechin derivatives","volume":"282","author":"Austin","year":"1992","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb0780","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/1568009619666191007112516","article-title":"Natural DNA Intercalators as promising therapeutics for Cancer and infectious diseases","volume":"20","author":"Godzieba","year":"2020","journal-title":"Curr. Cancer Drug Targets"},{"issue":"6","key":"10.1016\/j.bbagen.2026.130932_bb0785","first-page":"3341","article-title":"Baicalein induced apoptosis and autophagy of undifferentiated thyroid cancer cells by the ERK\/PI3K\/Akt pathway","volume":"11","author":"Wang","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.bbagen.2026.130932_bb0790","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.ijbiomac.2020.07.049","article-title":"In vitro and in silico assessment of DNA interaction, topoisomerase I and II inhibition properties of chrysosplenetin","volume":"163","author":"\u015e\u00f6hreto\u011flu","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"12","key":"10.1016\/j.bbagen.2026.130932_bb0795","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/ptr.3441","article-title":"Identification of chrysoplenetin from Vitex negundo as a potential cytotoxic agent against PANC-1 and a panel of 39 human cancer cell lines (JFCR-39)","volume":"25","author":"Awale","year":"2011","journal-title":"Phytother. Res."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb0800","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12935-021-01906-y","article-title":"Emerging cellular and molecular mechanisms underlying anticancer indications of chrysin","volume":"21","author":"Talebi","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbagen.2026.130932_bb0805","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2022.121666","article-title":"Infrared spectroscopy and flow cytometry studies on the apoptotic effect of nano-chrysin in HeLa cells","volume":"282","author":"Kamat","year":"2022","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"issue":"4","key":"10.1016\/j.bbagen.2026.130932_bb0810","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/15384101.2021.2020434","article-title":"Chrysin impairs genomic stability by suppressing DNA double-strand break repair in breast cancer cells","volume":"21","author":"Geng","year":"2022","journal-title":"Cell Cycle"},{"issue":"20","key":"10.1016\/j.bbagen.2026.130932_bb0815","doi-asserted-by":"crossref","first-page":"11246","DOI":"10.3390\/ijms222011246","article-title":"AK-I-190, a new catalytic inhibitor of topoisomerase II with anti-proliferative and pro-apoptotic activity on androgen-negative prostate Cancer cells","volume":"22","author":"Jeon","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb0820","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2025.2501377","article-title":"Synthesis, in vitro and in silico studies of a novel chrysin-ferrocene Schiff base with potent anticancer activity via G1 arrest, caspase-dependent apoptosis and inhibition of topoisomerase II","volume":"40","author":"Break","year":"2025","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bbagen.2026.130932_bb0825","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.phytol.2019.04.021","article-title":"Acacetin-A simple flavone exhibiting diverse pharmacological activities","volume":"32","author":"Semwal","year":"2019","journal-title":"Phytochem. Let."},{"key":"10.1016\/j.bbagen.2026.130932_bb0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111708","article-title":"Acacetin, a flavone with diverse therapeutic potential in cancer, inflammation, infections and other metabolic disorders","volume":"145","author":"Singh","year":"2020","journal-title":"Food Chem. Toxicol."},{"issue":"12","key":"10.1016\/j.bbagen.2026.130932_bb0835","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1007\/s00204-021-03162-5","article-title":"Topoisomerase poisoning by the flavonoid nevadensin triggers DNA damage and apoptosis in human colon carcinoma HT29 cells","volume":"95","author":"M\u00fcller","year":"2021","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb0840","first-page":"15","article-title":"Anti-tumor activity of wogonin, an extract from Scutellaria baicalensis, through regulating different signaling pathways","volume":"15","author":"Huynh","year":"2017","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.bbagen.2026.130932_bb0845","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ctrv.2008.09.005","article-title":"New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin","volume":"35","author":"Li-Weber","year":"2009","journal-title":"Cancer Treat. Rev."},{"issue":"6","key":"10.1016\/j.bbagen.2026.130932_bb0850","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3390\/molecules24061076","article-title":"Isoflavones","volume":"24","author":"K\u0159\u00ed\u017eov\u00e1","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bbagen.2026.130932_bb0855","first-page":"121","article-title":"Soy isoflavonoids and cancer metabolism at the target site","volume":"480-481","author":"Boersma","year":"2001","journal-title":"Mutat. Res."},{"key":"10.1016\/j.bbagen.2026.130932_bb0860","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.3389\/fphar.2019.01336","article-title":"Molecular mechanisms of action of genistein in cancer: recent advances","volume":"10","author":"Tuli","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"20","key":"10.1016\/j.bbagen.2026.130932_bb0865","doi-asserted-by":"crossref","first-page":"6097","DOI":"10.1021\/bi7000664","article-title":"Bioflavonoids as poisons of human topoisomerase II alpha and II beta","volume":"46","author":"Bandele","year":"2007","journal-title":"Biochem"},{"issue":"2","key":"10.1016\/j.bbagen.2026.130932_bb0870","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/oxfordjournals.jbchem.a124908","article-title":"Effects of protein tyrosine kinase inhibitors with different modes of action on topoisomerase activity and death of IL-2-dependent CTLL-2 cells","volume":"118","author":"Azuma","year":"1995","journal-title":"J. Biochem."},{"issue":"4","key":"10.1016\/j.bbagen.2026.130932_bb0875","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3892\/ijo.2013.2032","article-title":"Inhibitory effects of a major soy isoflavone, genistein, on human DNA topoisomerase II activity and cancer cell proliferation","volume":"43","author":"Mizushina","year":"2013","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb0880","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050175","article-title":"Genistein sensitizes bladder cancer cells to HCPT treatment in vitro and in vivo via ATM\/NF-\u03baB\/IKK pathway-induced apoptosis","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.bbagen.2026.130932_bb0885","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201800635","article-title":"Impact of oxidative metabolism on the cytotoxic and genotoxic potential of Genistein in human Colon Cancer cells","volume":"63","author":"Schroeter","year":"2019","journal-title":"Mol. Nutr. Food Res."},{"issue":"3","key":"10.1016\/j.bbagen.2026.130932_bb0890","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1002\/jcp.27082","article-title":"Genistein-induced DNA damage is repaired by nonhomologous end joining and homologous recombination in TK6 cells","volume":"234","author":"Hu","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbagen.2026.130932_bb0895","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104387","article-title":"Functional daidzein enhances the anticancer effect of topotecan and reverses BCRP-mediated drug resistance in breast cancer","volume":"147","author":"Guo","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbagen.2026.130932_bb0900","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6904-11-1","article-title":"Pharmacokinetics of phenoxodiol, a novel isoflavone, following intravenous administration to patients with advanced cancer","volume":"11","author":"Howes","year":"2011","journal-title":"BMC Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.bbagen.2026.130932_bb0905","first-page":"2581","article-title":"Phenoxodiol (2H-1-benzopyran-7-0,1,3-(4-hydroxyphenyl)), a novel isoflavone derivative, inhibits DNA topoisomerase II by stabilizing the cleavable complex","volume":"22","author":"Constantinou","year":"2002","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbagen.2026.130932_bb0910","first-page":"936","article-title":"Phenoxodiol sensitizes metastatic colorectal cancer cells to 5-fluorouracil- and oxaliplatin-induced apoptosis through intrinsic pathway","volume":"19","author":"Yaylaci","year":"2020","journal-title":"EXCLI J."},{"key":"10.1016\/j.bbagen.2026.130932_bb0915","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2020.137907","article-title":"Biochanin A: a novel bioactive multifunctional compound from nature","volume":"722","author":"Sarfraz","year":"2020","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.bbagen.2026.130932_bb0920","article-title":"Biochanin A induces S phase arrest and apoptosis in lung cancer cells","volume":"2018","author":"Li","year":"2018","journal-title":"Biomed. Res. Int."},{"issue":"3","key":"10.1016\/j.bbagen.2026.130932_bb0925","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/CAD.0000000000000044","article-title":"Biochanin A reduces pancreatic cancer survival and progression","volume":"25","author":"Bhardwaj","year":"2014","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.bbagen.2026.130932_bb0930","article-title":"Biochanin A suppresses tumor progression and PD-L1 expression via inhibiting ZEB1 expression in colorectal cancer","volume":"2022","author":"Xu","year":"2022","journal-title":"J. Oncol."},{"issue":"5","key":"10.1016\/j.bbagen.2026.130932_bb0935","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.3892\/or.2017.5953","article-title":"Biochanin-A induces apoptosis and suppresses migration in FaDu human pharynx squamous carcinoma cells","volume":"38","author":"Cho","year":"2017","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb0940","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s12672-022-00601-2","article-title":"Biochanin A inhibits lung adenocarcinoma progression by targeting ZEB1","volume":"13","author":"Li","year":"2022","journal-title":"Discov. Oncol."},{"issue":"3","key":"10.1016\/j.bbagen.2026.130932_bb0945","first-page":"2830","article-title":"Biochanin A extirpates the epithelial-mesenchymal transition in a human lung cancer","volume":"15","author":"Wang","year":"2018","journal-title":"Exp. Ther. Med."},{"issue":"4","key":"10.1016\/j.bbagen.2026.130932_bb0950","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1208\/s12249-016-0614-z","article-title":"Formulation and optimization of doxorubicin and Biochanin a combinational liposomes for reversal of chemoresistance","volume":"18","author":"Dash","year":"2017","journal-title":"AAPS Pharm Sci Tech."},{"issue":"3","key":"10.1016\/j.bbagen.2026.130932_bb0955","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/ptr.7388","article-title":"The natural isoflavone Biochanin-A synergizes 5-fluorouracil anticancer activity in vitro and in vivo in Ehrlich solid-phase carcinoma model","volume":"36","author":"Mahmoud","year":"2022","journal-title":"Phytother. Res."},{"issue":"2","key":"10.1016\/j.bbagen.2026.130932_bb0960","doi-asserted-by":"crossref","first-page":"12461","DOI":"10.1080\/21655979.2021.2005876","article-title":"Bioinformatics and in-silico findings reveal medical features and pharmacological targets of biochanin A against colorectal cancer and COVID-19","volume":"12","author":"Qin","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.bbagen.2026.130932_bb0965","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105264","article-title":"Naringin and naringenin as anticancer agents and adjuvants in cancer combination therapy: efficacy and molecular mechanisms of action, a comprehensive narrative review","volume":"171","author":"Memariani","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"8","key":"10.1016\/j.bbagen.2026.130932_bb0970","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.fct.2006.01.015","article-title":"Catalytic inhibition of human DNA topoisomerase by phenolic compounds in Ardisia compressa extracts and their effect on human colon cancer cells","volume":"44","author":"de Mej\u00eda","year":"2006","journal-title":"Food Chem. Toxicol."},{"issue":"5","key":"10.1016\/j.bbagen.2026.130932_bb0975","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/jcb.25729","article-title":"Naringenin-induced apoptotic cell death in prostate Cancer cells is mediated via the PI3K\/AKT and MAPK signaling pathways","volume":"118","author":"Lim","year":"2017","journal-title":"Cell Biochem."},{"key":"10.1016\/j.bbagen.2026.130932_bb0980","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.745111","article-title":"Naringenin regulates FKBP4\/NR3C1\/NRF2 Axis in autophagy and proliferation of breast cancer and differentiation and maturation of dendritic cell","volume":"12","author":"Xiong","year":"2022","journal-title":"Front. Immunol."},{"issue":"19","key":"10.1016\/j.bbagen.2026.130932_bb0985","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.3390\/molecules27196588","article-title":"Fermentation extract of Naringenin increases the expression of estrogenic receptor \u03b2 and modulates genes related to the p53 Signalling pathway, miR-200c and miR-141 in human Colon Cancer cells exposed to BPA","volume":"27","author":"Lozano-Herrera","year":"2022","journal-title":"Molecules"},{"issue":"18","key":"10.1016\/j.bbagen.2026.130932_bb0990","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1080\/14786419.2015.1107556","article-title":"A review on biological sources, chemistry and pharmacological activities of pinostrobin","volume":"30","author":"Patel","year":"2016","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.bbagen.2026.130932_bb0995","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jphotobiol.2017.01.010","article-title":"Allosteric inhibition of topoisomerase I by pinostrobin: molecular docking, spectroscopic and topoisomerase I activity studies","volume":"167","author":"Jadaun","year":"2017","journal-title":"J. Photochem. Photobiol. B"},{"issue":"2","key":"10.1016\/j.bbagen.2026.130932_bb1000","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191523","article-title":"Induction of apoptosis by pinostrobin in human cervical cancer cells: possible mechanism of action","volume":"13","author":"Jaudan","year":"2018","journal-title":"PLoS ONE"},{"issue":"21","key":"10.1016\/j.bbagen.2026.130932_bb1005","doi-asserted-by":"crossref","first-page":"12097","DOI":"10.1039\/C8RA08380K","article-title":"Pinostrobin inhibits proliferation and induces apoptosis in cancer stem-like cells through a reactive oxygen species-dependent mechanism","volume":"9","author":"Jadaun","year":"2019","journal-title":"RSC Adv."},{"issue":"9","key":"10.1016\/j.bbagen.2026.130932_bb1010","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/CAD.0b013e3281de7264","article-title":"Cudraflavanone A purified from Cudrania tricuspidata induces apoptotic cell death of human leukemia U937 cells, at least in part, through the inhibition of DNA topoisomerase I and protein kinase C activity","volume":"18","author":"Rho","year":"2007","journal-title":"Anti-Cancer Drugs"},{"issue":"3","key":"10.1016\/j.bbagen.2026.130932_bb1015","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1080\/10408398.2018.1541866","article-title":"Bioactive compounds from Cudrania tricuspidata: a natural anticancer source","volume":"60","author":"Li","year":"2020","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"7","key":"10.1016\/j.bbagen.2026.130932_bb1020","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s00210-023-02434-4","article-title":"Morus alba: a comprehensive phytochemical and pharmacological review","volume":"396","author":"Batiha","year":"2023","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"5","key":"10.1016\/j.bbagen.2026.130932_bb1025","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1177\/1535370220903671","article-title":"Molecular mechanisms of action of hesperidin in cancer: recent trends and advancements","volume":"245","author":"Aggarwal","year":"2020","journal-title":"Exp. Biol. Med."},{"issue":"Pt 3","key":"10.1016\/j.bbagen.2026.130932_bb1030","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1042\/BJ20040474","article-title":"Comparative analysis of topoisomerase IB inhibition and DNA intercalation by flavonoids and similar compounds: structural determinates of activity","volume":"384","author":"Webb","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbagen.2026.130932_bb1035","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2018.11.022","article-title":"Combined administration of naringenin and hesperetin with optimal ratio maximizes the anti-cancer effect in human pancreatic cancer via down regulation of FAK and p38 signaling pathway","volume":"58","author":"Lee","year":"2019","journal-title":"Phytomed"},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb1040","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40360-019-0301-2","article-title":"Apigenin and hesperidin augment the toxic effect of doxorubicin against HepG2 cells","volume":"20","author":"Korga","year":"2019","journal-title":"BMC Pharmacol. Toxicol."},{"issue":"9","key":"10.1016\/j.bbagen.2026.130932_bb1045","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1021\/tx050039n","article-title":"Anthocyanidins modulate the activity of human DNA topoisomerases I and II and affect cellular DNA integrity","volume":"18","author":"Habermeyer","year":"2005","journal-title":"Chem. Res. Toxicol."},{"issue":"3","key":"10.1016\/j.bbagen.2026.130932_bb1050","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1021\/tx800293v","article-title":"Delphinidin modulates the DNA-damaging properties of topoisomerase II poisons","volume":"22","author":"Esselen","year":"2009","journal-title":"Chem. Res. Toxicol."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb1055","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s12013-007-0037-2","article-title":"An overview of DNA and RNA bindings to antioxidant flavonoids","volume":"49","author":"Kanakis","year":"2007","journal-title":"Cell Biochem. Biophys."},{"issue":"2","key":"10.1016\/j.bbagen.2026.130932_bb1060","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201600462","article-title":"Genistein and delphinidin antagonize the genotoxic effects of the mycotoxin alternariol in human colon carcinoma cells","volume":"61","author":"Aichinger","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb1065","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3892\/ol.2017.6232","article-title":"Inhibitory effects of delphinidin on the proliferation of ovarian cancer cells via PI3K\/AKT and ERK 1\/2 MAPK signal transduction","volume":"14","author":"Lim","year":"2017","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.bbagen.2026.130932_bb1070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/01635589509514368","article-title":"The dietary anticancer agent ellagic acid is a potent inhibitor of DNA topoisomerases in vitro","volume":"23","author":"Constantinou","year":"1995","journal-title":"Nutr. Cancer"},{"issue":"36","key":"10.1016\/j.bbagen.2026.130932_bb1075","doi-asserted-by":"crossref","first-page":"9162","DOI":"10.1021\/jf302600q","article-title":"Ellagic acid and polyhydroxylated urolithins are potent catalytic inhibitors of human topoisomerase II: an in vitro study","volume":"60","author":"Furlanetto","year":"2012","journal-title":"J. Agric. Food Chem."},{"issue":"11","key":"10.1016\/j.bbagen.2026.130932_bb1080","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/BF02977368","article-title":"Inhibition of topoisomerase I activity and efflux drug transporters\u2019 expression by xanthohumol from hops","volume":"30","author":"Lee","year":"2007","journal-title":"Arch. Pharm. Res."},{"issue":"4","key":"10.1016\/j.bbagen.2026.130932_bb1085","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/mutage\/ger006","article-title":"Green tea constituents (\u2212)-epigallocatechin-3-gallate (EGCG) and gallic acid induce topoisomerase I- and topoisomerase II-DNA complexes in cells mediated by pyrogallol-induced hydrogen peroxide","volume":"26","author":"Lopez-Lazaro","year":"2011","journal-title":"Mutagenesis"},{"issue":"5","key":"10.1016\/j.bbagen.2026.130932_bb1090","first-page":"479","article-title":"Inhibitory effect of galangin on DNA topoisomerases in lung cancer cells","volume":"40","author":"Zhao","year":"2015","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.bbagen.2026.130932_bb1095","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2023.137115","article-title":"Opportunities and challenges in enhancing the bioavailability and bioactivity of dietary flavonoids: a novel delivery system perspective","volume":"430","author":"Yuan","year":"2024","journal-title":"Food Chem."},{"key":"10.1016\/j.bbagen.2026.130932_bb1100","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1134\/S0003683822090149","article-title":"Modern nanocarriers as a factor in increasing the efficiency of flavonoid delivery","volume":"58","author":"Zverev","year":"2022","journal-title":"Appl. Biochem. Microbiol."},{"issue":"8","key":"10.1016\/j.bbagen.2026.130932_bb1105","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/mnfr.201100117","article-title":"Enhancing the bioavailability of resveratrol by combining it with piperine","volume":"55","author":"Johnson","year":"2011","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.bbagen.2026.130932_bb1110","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijpharm.2013.01.050","article-title":"Liposomal encapsulation of the natural flavonoid fisetin improves bioavailability and antitumor efficacy","volume":"444","author":"Seguin","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb1115","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1080\/10717544.2021.1927244","article-title":"Enhancement of oral bioavailability of quercetin by metabolic inhibitory nanosuspensions compared to conventional nanosuspensions","volume":"28","author":"Li","year":"2021","journal-title":"Drug Deliv."},{"key":"10.1016\/j.bbagen.2026.130932_bb1120","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2022.111723","article-title":"Insights into PLGA-encapsulated epigallocatechin 3-gallate nanoparticles as a new potential biomedical system: a computational and experimental approach","volume":"182","author":"Minnelli","year":"2023","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.bbagen.2026.130932_bb1125","doi-asserted-by":"crossref","DOI":"10.1100\/2012\/637953","article-title":"A comprehensive review on pharmacotherapeutics of herbal bioenhancers","volume":"2012","author":"Dudhatra","year":"2012","journal-title":"Sci. World J."},{"issue":"2","key":"10.1016\/j.bbagen.2026.130932_bb1130","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/bab.2404","article-title":"Nanophytosomes of hesperidin and of hesperetin: preparation, characterization, and in vivo evaluation","volume":"70","author":"Omidfar","year":"2023","journal-title":"Biotechnol. Appl. Biochem."},{"issue":"6","key":"10.1016\/j.bbagen.2026.130932_bb1135","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1021\/bm5003009","article-title":"Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy","volume":"15","author":"Zhong","year":"2014","journal-title":"Biomacromolecules"},{"issue":"6","key":"10.1016\/j.bbagen.2026.130932_bb1140","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1111\/cas.14909","article-title":"Tumor-homing peptide and its utility for advanced cancer medicine","volume":"112","author":"Kondo","year":"2021","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.bbagen.2026.130932_bb1145","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/pharmaceutics16020248","article-title":"Different targeting ligands-mediated drug delivery systems for tumor therapy","volume":"16","author":"Yan","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bbagen.2026.130932_bb1150","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.648407","article-title":"Clinically-relevant ABC transporter for anti-Cancer drug resistance","volume":"12","author":"Xiao","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbagen.2026.130932_bb1155","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1184079","article-title":"Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers","volume":"13","author":"Lin","year":"2023","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb1160","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12935-023-02960-4","article-title":"Flavonoids target different molecules of autophagic and metastatic pathways in cancer cells","volume":"23","author":"Hosseinzadeh","year":"2023","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb1165","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12943-024-02165-x","article-title":"Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.bbagen.2026.130932_bb1170","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/s41416-019-0722-0","article-title":"Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progression","volume":"122","author":"Allain","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbagen.2026.130932_bb1175","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1348076","article-title":"Natural products reverse cancer multidrug resistance","volume":"15","author":"Zou","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbagen.2026.130932_bb1180","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3390\/ph18040494","article-title":"Modulation of the Main resistance-associated ABC transporter\u2019s expression by plant Flavonol Isorhamnetin","volume":"18","author":"Milutinovi\u0107","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"issue":"17","key":"10.1016\/j.bbagen.2026.130932_bb1185","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.3390\/cancers14174123","article-title":"Recent trends in nanomedicine-based strategies to overcome multidrug resistance in tumors","volume":"14","author":"Khan","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"21","key":"10.1016\/j.bbagen.2026.130932_bb1190","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.3390\/nu16213741","article-title":"Potential strategies for overcoming drug resistance pathways using Propolis and its polyphenolic\/flavonoid compounds in combination with chemotherapy and radiotherapy","volume":"16","author":"Or\u0161oli\u0107","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.bbagen.2026.130932_bb1195","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114519","article-title":"Exosomal PD-L1 in non-small cell lung cancer: implications for immune evasion and resistance to immunotherapy","volume":"155","author":"Tarin","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.bbagen.2026.130932_bb1200","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1080\/1061186X.2025.2467139","article-title":"Role of liposomes in chemoimmunotherapy of breast cancer","volume":"33","author":"Attarian","year":"2025","journal-title":"J. Drug Target."},{"issue":"4","key":"10.1016\/j.bbagen.2026.130932_bb1205","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/1061186X.2024.2433551","article-title":"Synergistic cancer treatment using porphyrin-based metal-organic frameworks for photodynamic and photothermal therapy","volume":"33","author":"Akbari Oryani","year":"2025","journal-title":"J. Drug Target."},{"key":"10.1016\/j.bbagen.2026.130932_bb1210","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2025.123656","article-title":"Advancements in chitosan-based nanocomposites with ZIF-8 nanoparticles: multifunctional platforms for wound healing applications","volume":"362","author":"Tarin","year":"2025","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.bbagen.2026.130932_bb1215","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111055","article-title":"Immunotherapy for colorectal cancer: rational strategies and novel therapeutic progress","volume":"126","author":"Rastin","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.bbagen.2026.130932_bb1220","first-page":"1691","article-title":"Quercetin-3-O-glucoside induces human DNA topoisomerase II inhibition, cell cycle arrest and apoptosis in hepatocellular carcinoma cells","volume":"34","author":"Sudan","year":"2014","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbagen.2026.130932_bb1225","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150977","article-title":"Quercetin exhibits cytotoxicity in cancer cells by inducing two-ended DNA double-strand breaks","volume":"739","author":"Someya","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2026.130932_bb1230","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1039\/C5RA22906E","article-title":"Greener synthesis and characterization, antimicrobial and cytotoxicity studies of gold nanoparticles of novel shapes and sizes","volume":"6","author":"Osonga","year":"2016","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130932_bb1235","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1593\/neo.04337","article-title":"Association between pterostilbene and quercetin inhibits metastatic activity of B16 melanoma","volume":"7","author":"Ferrer","year":"2005","journal-title":"Neoplasia"},{"issue":"13","key":"10.1016\/j.bbagen.2026.130932_bb1240","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.3390\/molecules28135246","article-title":"Epigallocatechin-3-gallate therapeutic potential in cancer: mechanism of action and clinical implications","volume":"28","author":"Kciuk","year":"2023","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.bbagen.2026.130932_bb1245","first-page":"1061","article-title":"The topoisomerase II inhibitor, genistein, induces G2\/M arrest and apoptosis in human malignant glioma cell lines","volume":"19","author":"Schmidt","year":"2008","journal-title":"Oncol. Rep."},{"issue":"7","key":"10.1016\/j.bbagen.2026.130932_bb1250","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.3390\/ijms10073255","article-title":"Genistein inhibition of topoisomerase II alpha expression participated by Sp1 and Sp3 in HeLa cell","volume":"10","author":"Zhou","year":"2009","journal-title":"Int. J. Mol. Sci."},{"issue":"1\u20134","key":"10.1016\/j.bbagen.2026.130932_bb1255","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.foodchem.2013.01.009","article-title":"Inhibitory effects of myricetin on mammalian DNA polymerase, topoisomerase and human cancer cell proliferation","volume":"139","author":"Shiomi","year":"2013","journal-title":"Food Chem."},{"issue":"14","key":"10.1016\/j.bbagen.2026.130932_bb1260","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.3390\/nu15143090","article-title":"Natural flavonoids quercetin and Kaempferol targeting G2\/M cell cycle-related genes and synergize with Smac mimetic LCL-161 to induce necroptosis in cholangiocarcinoma cells","volume":"15","author":"Lomphithak","year":"2023","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.bbagen.2026.130932_bb1265","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/s11095-010-0089-7","article-title":"Apigenin: a promising molecule for cancer prevention","volume":"27","author":"Shukla","year":"2010","journal-title":"Pharm. Res."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416526000322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416526000322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:31:53Z","timestamp":1793943113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416526000322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":253,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0304416526000322"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2026.130932","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Flavonoids: Novel topoisomerase inhibitors in cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2026.130932","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130932"}}